Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension

NCT02021292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Interventions

DRUG: Macitentan
DRUG: Placebo

Sponsor

Actelion